ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Chemizon Backs Korean R&D Start-up

February 25, 2008 | APPEARED IN VOLUME 86, ISSUE 8

The South Korean drug discovery services firm Chemizon will support a commercial spin-off from the Korean Research Institute of Bioscience & Biotechnology, the country's largest government-funded biology research institute. Chemizon will invest in the new venture, build its management capabilities, and assist it in turning its discoveries into small-molecule drugs. "KRIBB is one of the top technology innovators in Korea and brings a lot of 'targets' to the table," says Ramesh Subramanian, Chemizon's vice president of business development.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment